{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,15]],"date-time":"2026-10-15T09:48:46Z","timestamp":1792057726600,"version":"4.4.0"},"reference-count":68,"publisher":"Elsevier BV","issue":"10","license":[{"start":{"date-parts":[[2026,10,1]],"date-time":"2026-10-01T00:00:00Z","timestamp":1790812800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,10,1]],"date-time":"2026-10-01T00:00:00Z","timestamp":1790812800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2026,6,30]],"date-time":"2026-06-30T00:00:00Z","timestamp":1782777600000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"funder":[{"DOI":"10.13039\/100004328","name":"Genentech","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100004328","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","ophthalmologyscience.org","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Ophthalmology Science"],"published-print":{"date-parts":[[2026,10]]},"DOI":"10.1016\/j.xops.2026.101320","type":"journal-article","created":{"date-parts":[[2026,9,4]],"date-time":"2026-09-04T19:57:54Z","timestamp":1788551874000},"page":"101320","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":0,"title":["HONU: A Multicenter, Prospective, Observational Study of the Progression of Intermediate Age-Related Macular Degeneration"],"prefix":"10.1016","volume":"6","author":[{"given":"Robyn H.","family":"Guymer","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zhichao","family":"Wu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Simon S.","family":"Gao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Miao","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Verena","family":"Steffen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chen","family":"Chen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jiameng","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Katie M.","family":"Litts","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Michael C.","family":"Chang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Justin","family":"Elstrott","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Brian","family":"Yaspan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Seema","family":"Datta","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jeffrey R.","family":"Willis","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Liang","family":"Liu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0003-1083-1529","authenticated-orcid":false,"given":"Hao","family":"Chen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"14","key":"10.1016\/j.xops.2026.101320_bib1","doi-asserted-by":"crossref","first-page":"1419","DOI":"10.1056\/NEJMoa054481","article-title":"Ranibizumab for neovascular age-related macular degeneration","volume":"355","author":"Rosenfeld","year":"2006","journal-title":"N Engl J Med"},{"issue":"12","key":"10.1016\/j.xops.2026.101320_bib2","doi-asserted-by":"crossref","first-page":"2537","DOI":"10.1016\/j.ophtha.2012.09.006","article-title":"Intravitreal aflibercept (VEGF trap-eye) in wet age-related macular degeneration","volume":"119","author":"Heier","year":"2012","journal-title":"Ophthalmology"},{"issue":"10326","key":"10.1016\/j.xops.2026.101320_bib3","doi-asserted-by":"crossref","first-page":"729","DOI":"10.1016\/S0140-6736(22)00010-1","article-title":"Efficacy, durability, and safety of intravitreal faricimab up to every 16 weeks for neovascular age-related macular degeneration (TENAYA and LUCERNE): two randomised, double-masked, phase 3, non-inferiority trials","volume":"399","author":"Heier","year":"2022","journal-title":"Lancet"},{"issue":"10411","key":"10.1016\/j.xops.2026.101320_bib4","doi-asserted-by":"crossref","first-page":"1434","DOI":"10.1016\/S0140-6736(23)01520-9","article-title":"Pegcetacoplan for the treatment of geographic atrophy secondary to age-related macular degeneration (OAKS and DERBY): two multicentre, randomised, double-masked, sham-controlled, phase 3 trials","volume":"402","author":"Heier","year":"2023","journal-title":"Lancet"},{"issue":"10411","key":"10.1016\/j.xops.2026.101320_bib5","doi-asserted-by":"crossref","first-page":"1449","DOI":"10.1016\/S0140-6736(23)01583-0","article-title":"Efficacy and safety of avacincaptad pegol in patients with geographic atrophy (GATHER2): 12-month results from a randomised, double-masked, phase 3 trial","volume":"402","author":"Khanani","year":"2023","journal-title":"Lancet"},{"issue":"17","key":"10.1016\/j.xops.2026.101320_bib6","doi-asserted-by":"crossref","first-page":"3551","DOI":"10.1038\/s41433-023-02497-w","article-title":"Avacincaptad pegol for geographic atrophy secondary to age-related macular degeneration: 18-month findings from the GATHER1 trial","volume":"37","author":"Patel","year":"2023","journal-title":"Eye"},{"issue":"11","key":"10.1016\/j.xops.2026.101320_bib7","doi-asserted-by":"crossref","first-page":"2286","DOI":"10.1016\/j.ophtha.2015.07.029","article-title":"Joint associations of diet, lifestyle, and genes with age-related macular degeneration","volume":"122","author":"Meyers","year":"2015","journal-title":"Ophthalmology"},{"issue":"7","key":"10.1016\/j.xops.2026.101320_bib9","doi-asserted-by":"crossref","first-page":"692","DOI":"10.1001\/jamaophthalmol.2022.1640","article-title":"Long-term outcomes of adding Lutein\/Zeaxanthin and \u03c9-3 fatty acids to the AREDS supplements on age-related macular degeneration progression: AREDS2 report 28","volume":"140","author":"Chew","year":"2022","journal-title":"JAMA Ophthalmol"},{"issue":"19","key":"10.1016\/j.xops.2026.101320_bib10","doi-asserted-by":"crossref","first-page":"2005","DOI":"10.1001\/jama.2013.4997","article-title":"Lutein + zeaxanthin and omega-3 fatty acids for age-related macular degeneration: the Age-Related Eye Disease Study 2 (AREDS2) randomized clinical trial","volume":"309","year":"2013","journal-title":"JAMA"},{"issue":"6","key":"10.1016\/j.xops.2026.101320_bib11","doi-asserted-by":"crossref","first-page":"829","DOI":"10.1016\/j.ophtha.2018.09.015","article-title":"Subthreshold nanosecond laser intervention in age-related macular degeneration: the LEAD randomized controlled clinical trial","volume":"126","author":"Guymer","year":"2019","journal-title":"Ophthalmology"},{"issue":"11","key":"10.1016\/j.xops.2026.101320_bib12","doi-asserted-by":"crossref","first-page":"1974","DOI":"10.1016\/j.ophtha.2006.08.015","article-title":"Laser treatment in patients with bilateral large drusen: the complications of age-related macular degeneration prevention trial","volume":"113","year":"2006","journal-title":"Ophthalmology"},{"issue":"2","key":"10.1016\/j.xops.2026.101320_bib13","doi-asserted-by":"crossref","first-page":"953","DOI":"10.1007\/s40123-022-00640-6","article-title":"LIGHTSITE II randomized multicenter trial: evaluation of multiwavelength photobiomodulation in non-exudative age-related macular degeneration","volume":"12","author":"Burton","year":"2023","journal-title":"Ophthalmol Ther"},{"issue":"3","key":"10.1016\/j.xops.2026.101320_bib14","doi-asserted-by":"crossref","first-page":"487","DOI":"10.1097\/IAE.0000000000003980","article-title":"Lightsite III: 13-Month efficacy and safety evaluation of multiwavelength photobiomodulation in nonexudative (Dry) age-related macular degeneration using the lumithera valeda light delivery System","volume":"44","author":"Boyer","year":"2024","journal-title":"Retina"},{"issue":"12","key":"10.1016\/j.xops.2026.101320_bib15","doi-asserted-by":"crossref","first-page":"2415","DOI":"10.1016\/j.ophtha.2014.06.034","article-title":"Optical coherence tomography-defined changes preceding the development of drusen-associated atrophy in age-related macular degeneration","volume":"121","author":"Wu","year":"2014","journal-title":"Ophthalmology"},{"issue":"6","key":"10.1016\/j.xops.2026.101320_bib16","doi-asserted-by":"crossref","first-page":"568","DOI":"10.1016\/j.oret.2019.12.011","article-title":"Prospective longitudinal evaluation of nascent geographic atrophy in age-related macular degeneration","volume":"4","author":"Wu","year":"2020","journal-title":"Ophthalmol Retina"},{"issue":"3","key":"10.1016\/j.xops.2026.101320_bib17","doi-asserted-by":"crossref","first-page":"394","DOI":"10.1016\/j.ophtha.2019.09.035","article-title":"Incomplete retinal pigment epithelial and outer retinal atrophy in age-related macular degeneration: classification of atrophy meeting report 4","volume":"127","author":"Guymer","year":"2020","journal-title":"Ophthalmology"},{"issue":"2","key":"10.1016\/j.xops.2026.101320_bib18","doi-asserted-by":"crossref","first-page":"205","DOI":"10.1016\/j.ophtha.2022.09.004","article-title":"Incomplete retinal pigment epithelial and outer retinal atrophy: longitudinal evaluation in age-related macular degeneration","volume":"130","author":"Wu","year":"2023","journal-title":"Ophthalmology"},{"issue":"7","key":"10.1016\/j.xops.2026.101320_bib19","doi-asserted-by":"crossref","first-page":"1224","DOI":"10.1097\/IAE.0000000000004080","article-title":"Complete retinal pigment epithelial and outer retinal atrophy in age-related macular degeneration: a Longitudinal Evaluation","volume":"44","author":"Wu","year":"2024","journal-title":"Retina"},{"issue":"4","key":"10.1016\/j.xops.2026.101320_bib20","doi-asserted-by":"crossref","first-page":"537","DOI":"10.1016\/j.ophtha.2017.09.028","article-title":"Consensus definition for atrophy associated with age-related macular degeneration on OCT: classification of atrophy report 3","volume":"125","author":"Sadda","year":"2018","journal-title":"Ophthalmology"},{"key":"10.1016\/j.xops.2026.101320_bib21","doi-asserted-by":"crossref","DOI":"10.1016\/j.preteyeres.2021.101017","article-title":"Reticular pseudodrusen: a critical phenotype in age-related macular degeneration","volume":"88","author":"Wu","year":"2022","journal-title":"Prog Retin Eye Res"},{"issue":"12","key":"10.1016\/j.xops.2026.101320_bib22","doi-asserted-by":"crossref","first-page":"1659","DOI":"10.1016\/j.ophtha.2019.07.022","article-title":"Prevalence, risk, and genetic Association of reticular pseudodrusen in age-related macular degeneration: Age-Related eye disease Study 2 report 21","volume":"126","author":"Domalpally","year":"2019","journal-title":"Ophthalmology"},{"issue":"10","key":"10.1016\/j.xops.2026.101320_bib23","doi-asserted-by":"crossref","first-page":"1107","DOI":"10.1016\/j.ophtha.2022.05.021","article-title":"Reticular pseudodrusen: the third macular risk feature for progression to late age-related macular degeneration: Age-Related eye disease Study 2 report 30","volume":"129","author":"Agr\u00f3n","year":"2022","journal-title":"Ophthalmology"},{"issue":"2","key":"10.1016\/j.xops.2026.101320_bib24","doi-asserted-by":"crossref","DOI":"10.1016\/j.xops.2022.100160","article-title":"Machine learning OCT predictors of progression from intermediate age-related macular degeneration to geographic atrophy and vision loss","volume":"2","author":"Lad","year":"2022","journal-title":"Ophthalmol Sci"},{"issue":"9","key":"10.1016\/j.xops.2026.101320_bib25","doi-asserted-by":"crossref","first-page":"1764","DOI":"10.1016\/j.ophtha.2017.06.032","article-title":"Optical coherence tomography predictors of risk for progression to non-neovascular atrophic age-related macular degeneration","volume":"124","author":"Sleiman","year":"2017","journal-title":"Ophthalmology"},{"issue":"1","key":"10.1016\/j.xops.2026.101320_bib26","doi-asserted-by":"crossref","first-page":"31","DOI":"10.1016\/j.oret.2019.08.003","article-title":"Prognostic value of retinal layers in comparison with other risk factors for conversion of intermediate age-related macular degeneration","volume":"4","author":"Thiele","year":"2020","journal-title":"Ophthalmol Retina"},{"key":"10.1016\/j.xops.2026.101320_bib27","doi-asserted-by":"crossref","first-page":"202","DOI":"10.1016\/j.ajo.2022.03.007","article-title":"Reticular pseudodrusen on the risk of progression in intermediate age-related macular degeneration","volume":"239","author":"Wu","year":"2022","journal-title":"Am J Ophthalmol"},{"key":"10.1016\/j.xops.2026.101320_bib28","doi-asserted-by":"crossref","first-page":"782","DOI":"10.1016\/j.survophthal.2018.05.005","article-title":"Subretinal drusenoid deposits AKA pseudodrusen","volume":"63","author":"Spaide","year":"2018","journal-title":"Surv Ophthalmol"},{"issue":"5","key":"10.1016\/j.xops.2026.101320_bib29","doi-asserted-by":"crossref","first-page":"1038","DOI":"10.1016\/j.ophtha.2012.10.018","article-title":"Progression of intermediate age-related macular degeneration with proliferation and inner retinal migration of hyperreflective foci","volume":"120","author":"Christenbury","year":"2013","journal-title":"Ophthalmology"},{"issue":"4","key":"10.1016\/j.xops.2026.101320_bib30","doi-asserted-by":"crossref","first-page":"757","DOI":"10.1016\/j.ajo.2014.06.021","article-title":"Optical coherence tomography-based measurement of drusen load predicts development of advanced age-related macular degeneration","volume":"158","author":"Nathoo","year":"2014","journal-title":"Am J Ophthalmol"},{"issue":"1","key":"10.1016\/j.xops.2026.101320_bib31","doi-asserted-by":"crossref","first-page":"39","DOI":"10.1016\/j.ophtha.2015.09.016","article-title":"Drusen volume and retinal pigment epithelium abnormal thinning volume predict 2-Year progression of age-related macular degeneration","volume":"123","author":"Folgar","year":"2016","journal-title":"Ophthalmology"},{"issue":"5","key":"10.1016\/j.xops.2026.101320_bib32","doi-asserted-by":"crossref","first-page":"422","DOI":"10.1111\/ceo.12685","article-title":"Ellipsoid zone on optical coherence tomography: a review","volume":"44","author":"Tao","year":"2016","journal-title":"Clin Exp Ophthalmol"},{"issue":"2","key":"10.1016\/j.xops.2026.101320_bib33","doi-asserted-by":"crossref","first-page":"118","DOI":"10.1016\/j.oret.2020.06.026","article-title":"Predicting progression of age-related macular degeneration using OCT and fundus photography","volume":"5","author":"Wu","year":"2021","journal-title":"Ophthalmol Retina"},{"key":"10.1016\/j.xops.2026.101320_bib34","doi-asserted-by":"crossref","first-page":"399","DOI":"10.1159\/000510887","article-title":"Can the onset of atrophic age-related macular degeneration be an acceptable endpoint for preventative trials?","volume":"243","author":"Wu","year":"2020","journal-title":"Ophthalmologica"},{"key":"10.1016\/j.xops.2026.101320_bib35","doi-asserted-by":"crossref","DOI":"10.1016\/j.xops.2025.100777","article-title":"Onset of end-stage atrophic age-related macular degeneration as an end Point\u2014A Delphi Study: classification of atrophy meetings report 7","volume":"5","author":"Wu","year":"2025","journal-title":"Ophthalmol Sci"},{"issue":"8","key":"10.1016\/j.xops.2026.101320_bib36","first-page":"2754","article-title":"HONU: a multicenter, prospective, observational study of the progression of intermediate age-related macular degeneration","volume":"64","author":"Guymer","year":"2023","journal-title":"Invest Ophthalmol Vis Sci"},{"issue":"2","key":"10.1016\/j.xops.2026.101320_bib37","doi-asserted-by":"crossref","DOI":"10.1016\/j.xops.2023.100419","article-title":"Targeted high-density microperimetry testing of nascent geographic atrophy in age-related macular degeneration","volume":"4","author":"Wu","year":"2023","journal-title":"Ophthalmol Sci"},{"key":"10.1016\/j.xops.2026.101320_bib38","article-title":"Functional evaluation of retinal pigment epithelium and outer retinal atrophy by high-density targeted microperimetry testing","volume":"4","author":"Wu","year":"2023","journal-title":"Ophthalmol Sci"},{"issue":"5","key":"10.1016\/j.xops.2026.101320_bib39","doi-asserted-by":"crossref","first-page":"412","DOI":"10.1016\/j.oret.2024.12.007","article-title":"Local OCT structural correlates of deep visual sensitivity defects in early atrophic age-related macular degeneration","volume":"9","author":"Saeed","year":"2025","journal-title":"Ophthalmol Retina"},{"issue":"7","key":"10.1016\/j.xops.2026.101320_bib40","first-page":"2794","article-title":"Patient-tailored fundus-controlled perimetry testing in intermediate and early atrophic age-related macular degeneration","volume":"65","author":"Schmitz-Valckenberg","year":"2024","journal-title":"Invest Ophthalmol Vis Sci"},{"key":"10.1016\/j.xops.2026.101320_bib41","series-title":"Medical Image Computing and Computer Assisted Intervention, 2023, MICCAI 2023 Lecture Notes in Computer Science, 14220","first-page":"477","article-title":"Weakly supervised lesion localization of nascent geographic atrophy in age-related macular degeneration","author":"Yao","year":"2023"},{"key":"10.1016\/j.xops.2026.101320_bib42","series-title":"Artificial Intelligence Quantified Outer Retinal Disruption On Optical Coherence Tomography As Clinical Endpoints For Geographic Atrophy","author":"Pely","year":"2024"},{"issue":"2","key":"10.1016\/j.xops.2026.101320_bib43","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1167\/tvst.14.2.11","article-title":"Deep learning approaches to predict geographic atrophy progression using three-dimensional OCT imaging","volume":"14","author":"Yoshida","year":"2025","journal-title":"Transl Vis Sci Technol"},{"issue":"1","key":"10.1016\/j.xops.2026.101320_bib44","doi-asserted-by":"crossref","first-page":"5","DOI":"10.1167\/tvst.10.1.5","article-title":"Development of the vision impairment in low luminance questionnaire","volume":"10","author":"Pondorfer","year":"2021","journal-title":"Transl Vis Sci Technol"},{"key":"10.1016\/j.xops.2026.101320_bib45","doi-asserted-by":"crossref","DOI":"10.1016\/j.xops.2025.100769","article-title":"Loss of OCT outer retinal bands as potential clinical trial endpoints in intermediate age-related macular degeneration","volume":"5","author":"Wu","year":"2025","journal-title":"Ophthalmol Sci"},{"issue":"6","key":"10.1016\/j.xops.2026.101320_bib46","doi-asserted-by":"crossref","first-page":"573","DOI":"10.1016\/S0197-2456(99)00031-8","article-title":"The Age-Related Eye Disease Study (AREDS): design implications. AREDS report no. 1","volume":"20","year":"1999","journal-title":"Control Clin Trials"},{"issue":"7","key":"10.1016\/j.xops.2026.101320_bib47","doi-asserted-by":"crossref","first-page":"692","DOI":"10.1001\/jamaophthalmol.2022.1640","article-title":"AREDS2 research group. Long-term outcomes of adding Lutein\/Zeaxanthin and \u03c9-3 fatty acids to the AREDS supplements on age-related macular degeneration progression: AREDS2 report 28","volume":"140","author":"Chew","year":"2022","journal-title":"JAMA Ophthalmol"},{"issue":"2","key":"10.1016\/j.xops.2026.101320_bib48","doi-asserted-by":"crossref","first-page":"130","DOI":"10.1001\/jamaophthalmol.2022.5404","article-title":"Association of dietary Nitrate and a mediterranean diet with age-related macular degeneration among US adults: the age-related eye disease Study (AREDS) and AREDS2","volume":"141","author":"Broadhead","year":"2023","journal-title":"JAMA Ophthalmol"},{"issue":"4","key":"10.1016\/j.xops.2026.101320_bib49","doi-asserted-by":"crossref","first-page":"470","DOI":"10.1001\/archophthalmol.2010.314","article-title":"Healthy lifestyles related to subsequent prevalence of age-related macular degeneration","volume":"129","author":"Mares","year":"2011","journal-title":"Arch Ophthalmol"},{"key":"10.1016\/j.xops.2026.101320_bib50","article-title":"Nutritional and lifestyle interventions for age-related macular degeneration: a review","volume":"2017","author":"Carneiro","year":"2017","journal-title":"Oxid Med Cell Longev"},{"issue":"4","key":"10.1016\/j.xops.2026.101320_bib51","doi-asserted-by":"crossref","first-page":"844","DOI":"10.1016\/j.ophtha.2012.10.036","article-title":"Clinical classification of age-related macular degeneration","volume":"120","author":"Ferris","year":"2013","journal-title":"Ophthalmology"},{"key":"10.1016\/j.xops.2026.101320_bib52","doi-asserted-by":"crossref","first-page":"1093","DOI":"10.1016\/j.oret.2024.05.014","article-title":"Screen failures in clinical trials in retina","volume":"8","author":"Hasan","year":"2024","journal-title":"Ophthalmol Retina"},{"issue":"8","key":"10.1016\/j.xops.2026.101320_bib53","doi-asserted-by":"crossref","first-page":"1572","DOI":"10.1016\/j.ophtha.2014.02.023","article-title":"Proposed lexicon for anatomic landmarks in normal posterior segment spectral-domain optical coherence tomography: the IN\u2022OCT consensus","volume":"121","author":"Staurenghi","year":"2014","journal-title":"Ophthalmology"},{"key":"10.1016\/j.xops.2026.101320_bib54","doi-asserted-by":"crossref","first-page":"445","DOI":"10.1097\/IAE.0000000000001946","article-title":"Optical coherence tomography and histology of age-related macular degeneration support mitochondria as reflectivity sources","volume":"38","author":"Litts","year":"2018","journal-title":"Retina"},{"issue":"12","key":"10.1016\/j.xops.2026.101320_bib55","doi-asserted-by":"crossref","first-page":"7889","DOI":"10.1167\/iovs.12-10765","article-title":"The IS\/OS junction layer in the natural history of type 2 idiopathic macular telangiectasia","volume":"53","author":"Sallo","year":"2012","journal-title":"Invest Ophthalmol Vis Sci"},{"issue":"8","key":"10.1016\/j.xops.2026.101320_bib56","doi-asserted-by":"crossref","first-page":"4450","DOI":"10.1167\/iovs.12-9848","article-title":"Characterization of fusarium keratitis outbreak isolates: contribution of biofilms to antimicrobial resistance and pathogenesis","volume":"53","author":"Mukherjee","year":"2012","journal-title":"Invest Ophthalmol Vis Sci"},{"issue":"7","key":"10.1016\/j.xops.2026.101320_bib57","doi-asserted-by":"crossref","first-page":"e998","DOI":"10.1111\/aos.14110","article-title":"Progression characteristics of ellipsoid zone loss in macular telangiectasia type 2","volume":"97","author":"Pauleikhoff","year":"2019","journal-title":"Acta Ophthalmol"},{"issue":"7","key":"10.1016\/j.xops.2026.101320_bib58","doi-asserted-by":"crossref","first-page":"1412","DOI":"10.1016\/j.ophtha.2012.01.026","article-title":"Hyporeflective wedge-shaped band in geographic atrophy secondary to age-related macular degeneration: an underreported finding","volume":"119","author":"Mon\u00e9s","year":"2012","journal-title":"Ophthalmology"},{"issue":"4","key":"10.1016\/j.xops.2026.101320_bib59","doi-asserted-by":"crossref","first-page":"802","DOI":"10.1097\/IAE.0000000000002461","article-title":"Clinicopathologic correlation of geographic atrophy secondary to age-related macular degeneration","volume":"39","author":"Li","year":"2019","journal-title":"Retina"},{"issue":"5","key":"10.1016\/j.xops.2026.101320_bib60","doi-asserted-by":"crossref","first-page":"325","DOI":"10.1016\/j.jcjo.2021.01.005","article-title":"Natural history of incomplete retinal pigment epithelial and outer retinal atrophy in age-related macular degeneration","volume":"56","author":"Corradetti","year":"2021","journal-title":"Can J Ophthalmol"},{"issue":"6","key":"10.1016\/j.xops.2026.101320_bib61","doi-asserted-by":"crossref","first-page":"839","DOI":"10.1136\/bjophthalmol-2020-318494","article-title":"Contrast sensitivity function in patients with macular disease and good visual acuity","volume":"106","author":"Wai","year":"2022","journal-title":"Br J Ophthalmol"},{"key":"10.1016\/j.xops.2026.101320_bib62","doi-asserted-by":"crossref","first-page":"148","DOI":"10.1016\/j.ajo.2021.01.017","article-title":"Normal-and low-luminance automated quantitative contrast sensitivity assessment in eyes with age-related macular degeneration","volume":"226","author":"Ou","year":"2021","journal-title":"Am J Ophthalmol"},{"issue":"1","key":"10.1016\/j.xops.2026.101320_bib63","doi-asserted-by":"crossref","first-page":"269","DOI":"10.1016\/j.cell.2020.08.036","article-title":"A quantitative proteome map of the human body","volume":"183","author":"Jiang","year":"2020","journal-title":"Cell"},{"issue":"7982","key":"10.1016\/j.xops.2026.101320_bib64","doi-asserted-by":"crossref","first-page":"329","DOI":"10.1038\/s41586-023-06592-6","article-title":"Plasma proteomic associations with genetics and health in the UK Biobank","volume":"622","author":"Sun","year":"2023","journal-title":"Nature"},{"issue":"1","key":"10.1016\/j.xops.2026.101320_bib65","doi-asserted-by":"crossref","first-page":"196","DOI":"10.1186\/s12886-020-01467-0","article-title":"Functionally validated imaging endpoints in the Alabama study on early age-related macular degeneration 2 (ALSTAR2): design and methods","volume":"20","author":"Curcio","year":"2020","journal-title":"BMC Ophthalmol"},{"issue":"1","key":"10.1016\/j.xops.2026.101320_bib66","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1080\/17469899.2023.2287178","article-title":"Rod mediated dark adaptation, a functional test for early and intermediate AMD outcomes","volume":"19","author":"Owsley","year":"2024","journal-title":"Expert Rev Ophthalmol"},{"key":"10.1016\/j.xops.2026.101320_bib67","doi-asserted-by":"crossref","DOI":"10.1167\/iovs.65.2.1","article-title":"Potential structural biomarkers in 3D images validated by the first functional biomarker for early age-related macular degeneration \u2013 ALSTAR2 Baseline","volume":"65","author":"Fasih-Ahmad","year":"2024","journal-title":"Invest Ophthalmol Vis Sci"},{"key":"10.1016\/j.xops.2026.101320_bib68","doi-asserted-by":"crossref","first-page":"659","DOI":"10.1186\/s13063-020-04595-6","article-title":"Clinical study protocol for a low interventional study in intermediate age-related macular degeneration developing novel clinical endpoints for interventional clinical trials with a regulatory and patient access intention - MACUSTAR","volume":"21","author":"Terheyden","year":"2020","journal-title":"Trials"},{"issue":"6","key":"10.1016\/j.xops.2026.101320_bib69","doi-asserted-by":"crossref","first-page":"1275","DOI":"10.1038\/s41433-022-02097-0","article-title":"Developing and validating a multivariable prediction model which predicts progression of intermediate to late age-related macular degeneration-the PINNACLE trial protocol","volume":"37","author":"Sutton","year":"2023","journal-title":"Eye (Lond)"}],"container-title":["Ophthalmology Science"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2666914526002587?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2666914526002587?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,10,15]],"date-time":"2026-10-15T09:24:07Z","timestamp":1792056247000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2666914526002587"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,10]]},"references-count":68,"journal-issue":{"issue":"10","published-print":{"date-parts":[[2026,10]]}},"alternative-id":["S2666914526002587"],"URL":"https:\/\/doi.org\/10.1016\/j.xops.2026.101320","relation":{},"ISSN":["2666-9145"],"issn-type":[{"value":"2666-9145","type":"print"}],"subject":[],"published":{"date-parts":[[2026,10]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"HONU: A Multicenter, Prospective, Observational Study of the Progression of Intermediate Age-Related Macular Degeneration","name":"articletitle","label":"Article Title"},{"value":"Ophthalmology Science","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.xops.2026.101320","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 Published by Elsevier Inc. on behalf of American Academy of Ophthalmology, Inc.","name":"copyright","label":"Copyright"}],"article-number":"101320"}}